Status:
COMPLETED
Different Modalities in Reducing Airborne Particulate Concentrations During AGP for Health Volunteers
Lead Sponsor:
Rush University Medical Center
Conditions:
Transmission, Patient-Professional
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Several clinical procedures have been described as aerosol generating procedure (AGP), including nebulization, high-flow nasal cannula oxygen therapy, noninvasive ventilation, and bronchial hygiene tr...
Eligibility Criteria
Inclusion
- • Ages 18-65, Male or Female
Exclusion
- Chronic lung disease, including asthma, COPD, etc.
- Upper airway anatomical abnormities
- Pregnancy
- Uncontrolled Diabetes, hypertension, or untreated thyroid disease
- Has any of the following symptoms in the last 21 days: sore throat, cough, chills, body aches for unknown reasons, shortness of breath for unknown reasons, loss of smell, loss of taste, fever at or greater than 100 degrees Fahrenheit.
- COVID-19 test positive within 21 days.
Key Trial Info
Start Date :
January 24 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 13 2021
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT04681599
Start Date
January 24 2021
End Date
April 13 2021
Last Update
April 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rush University Medical Center
Chicago, Illinois, United States, 60612